| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
A multicenter phase II study of cetuximab in combination with chest radiotherapy and consolidation chemotherapy in patients with stage III non-small cell lung cancer
|
Ramalingam, S.S.
|
|
2013
|
81 |
3 |
p. 416-421
|
artikel
|
| 2 |
An extremely rare case of small-cell lung cancer harboring variant 2 of the EML4-ALK fusion gene
|
Toyokawa, Gouji
|
|
2013
|
81 |
3 |
p. 487-490
|
artikel
|
| 3 |
A phase II clinical trial of the Vascular Disrupting Agent BNC105P as second line chemotherapy for advanced Malignant Pleural Mesothelioma
|
Nowak, Anna K.
|
|
2013
|
81 |
3 |
p. 422-427
|
artikel
|
| 4 |
A phase I/II trial of Tumor Treating Fields (TTFields) therapy in combination with pemetrexed for advanced non-small cell lung cancer
|
Pless, Miklos
|
|
2013
|
81 |
3 |
p. 445-450
|
artikel
|
| 5 |
Arginase-1 mRNA expression correlates with myeloid-derived suppressor cell levels in peripheral blood of NSCLC patients
|
Heuvers, Marlies E.
|
|
2013
|
81 |
3 |
p. 468-474
|
artikel
|
| 6 |
Clinical evaluation of microRNA expression profiling in non small cell lung cancer
|
Markou, A.
|
|
2013
|
81 |
3 |
p. 388-396
|
artikel
|
| 7 |
Clinical significance of the frequency of regulatory T cells in regional lymph node lymphocytes as a prognostic factor for non-small-cell lung cancer
|
Hanagiri, Takeshi
|
|
2013
|
81 |
3 |
p. 475-479
|
artikel
|
| 8 |
Contents
|
|
|
2013
|
81 |
3 |
p. v-vii
|
artikel
|
| 9 |
Corrigendum to “Tumor biomarkers in lung cancer: An analysis of patients with pathologically staged N1 non small cell lung cancer (NSCLC)” [Lung Cancer 18 (S1) (1997) 160]
|
Komaki, R.
|
|
2013
|
81 |
3 |
p. 497
|
artikel
|
| 10 |
Crizotinib-induced esophageal ulceration: A novel adverse event of crizotinib
|
Park, Jangchul
|
|
2013
|
81 |
3 |
p. 495-496
|
artikel
|
| 11 |
Editorial Board
|
|
|
2013
|
81 |
3 |
p. iii
|
artikel
|
| 12 |
EGFR tyrosine kinase inhibitors beyond focal progression obtain a prolonged disease control in patients with advanced adenocarcinoma of the lung
|
Conforti, Fabio
|
|
2013
|
81 |
3 |
p. 440-444
|
artikel
|
| 13 |
Erlotinib-induced autophagy in epidermal growth factor receptor mutated non-small cell lung cancer
|
Li, Yuan-yuan
|
|
2013
|
81 |
3 |
p. 354-361
|
artikel
|
| 14 |
Fibroblast growth factor receptor 1 (FGFR1) copy number is an independent prognostic factor in non-small cell lung cancer
|
Tran, Thang N.
|
|
2013
|
81 |
3 |
p. 462-467
|
artikel
|
| 15 |
Frequency of EGFR and KRAS mutations in patients with non small cell lung cancer by racial background: Do disparities exist?
|
Bauml, Joshua
|
|
2013
|
81 |
3 |
p. 347-353
|
artikel
|
| 16 |
High grade neuroendocrine lung tumors: Pathological characteristics, surgical management and prognostic implications
|
Grand, Bertrand
|
|
2013
|
81 |
3 |
p. 404-409
|
artikel
|
| 17 |
History of lung disease and risk of lung cancer in a population with high household fuel combustion exposures in rural China
|
HosgoodIII, H. Dean
|
|
2013
|
81 |
3 |
p. 343-346
|
artikel
|
| 18 |
Impact of epidermal growth factor receptor mutations on intracranial treatment response and survival after brain metastases in lung adenocarcinoma patients
|
Hsiao, Shih-Hsin
|
|
2013
|
81 |
3 |
p. 455-461
|
artikel
|
| 19 |
Impact of physical size on gefitinib efficacy in patients with non-small cell lung cancer harboring EGFR mutations
|
Ichihara, Eiki
|
|
2013
|
81 |
3 |
p. 435-439
|
artikel
|
| 20 |
KIF5B/RET fusion gene analysis in a selected series of cytological specimens of EGFR, KRAS and EML4-ALK wild-type adenocarcinomas of the lung
|
Borrelli, Nicla
|
|
2013
|
81 |
3 |
p. 377-381
|
artikel
|
| 21 |
Lung cancer following lung transplant: Single institution 10 year experience
|
Belli, E.V.
|
|
2013
|
81 |
3 |
p. 451-454
|
artikel
|
| 22 |
Mechanisms of resistance to EGFR tyrosine kinase inhibitors gefitinib/erlotinib and to ALK inhibitor crizotinib
|
Tartarone, Alfredo
|
|
2013
|
81 |
3 |
p. 328-336
|
artikel
|
| 23 |
Overexpression of beclin1 induced autophagy and apoptosis in lungs of K-rasLA1 mice
|
Shin, Ji Young
|
|
2013
|
81 |
3 |
p. 362-370
|
artikel
|
| 24 |
Phase II study of pemetrexed and cisplatin plus cetuximab followed by pemetrexed and cetuximab maintenance therapy in patients with advanced nonsquamous non-small cell lung cancer
|
Schmid-Bindert, Gerald
|
|
2013
|
81 |
3 |
p. 428-434
|
artikel
|
| 25 |
Planning of segmentectomy using three-dimensional computed tomography angiography with a virtual safety margin: Technique and initial experience
|
Iwano, Shingo
|
|
2013
|
81 |
3 |
p. 410-415
|
artikel
|
| 26 |
Platinum rechallenge in patients with advanced NSCLC: A pooled analysis
|
Petrelli, Fausto
|
|
2013
|
81 |
3 |
p. 337-342
|
artikel
|
| 27 |
Potentialities of aberrantly methylated circulating DNA for diagnostics and post-treatment follow-up of lung cancer patients
|
Ponomaryova, Anastasia A.
|
|
2013
|
81 |
3 |
p. 397-403
|
artikel
|
| 28 |
Systematic review of pleurectomy in the treatment of malignant pleural mesothelioma
|
Cao, Christopher
|
|
2013
|
81 |
3 |
p. 319-327
|
artikel
|
| 29 |
The first case of lung carcinosarcoma harboring in-frame deletions at exon19 in the EGFR gene
|
Toyokawa, Gouji
|
|
2013
|
81 |
3 |
p. 491-494
|
artikel
|
| 30 |
The format type has impact on the quality of pathology reports of oncological lung resection specimens
|
Aumann, Konrad
|
|
2013
|
81 |
3 |
p. 382-387
|
artikel
|
| 31 |
The influence of smoking intensity on the clinicopathologic features and survival of patients with surgically treated non-small cell lung cancer
|
Park, Seong Yong
|
|
2013
|
81 |
3 |
p. 480-486
|
artikel
|
| 32 |
The role of epigenetics in malignant pleural mesothelioma
|
Vandermeers, Fabian
|
|
2013
|
81 |
3 |
p. 311-318
|
artikel
|
| 33 |
The utility of the proposed IASLC/ATS/ERS lung adenocarcinoma subtypes for disease prognosis and correlation of driver gene alterations
|
Tsuta, Koji
|
|
2013
|
81 |
3 |
p. 371-376
|
artikel
|
Tijdschrift beschrijving